Mitochondrial

NMN

nicotinamide mononucleotide · β-NMN · beta-NMN

Oral NAD+ precursor (nicotinamide mononucleotide). Supplement / research ingredient, not a peptide, not injectable NAD+ IV folklore, and not interchangeable with NR on this leaf. Use the NAD+ leaf for the coenzyme identity.

Not FDA-approved - research chemical

Reviewed by CalcMyPeptide Editorial Team

·Last updated: September 2026·Evidence: Moderate

Typical research dose

Oral NAD+ precursor - not a peptide vial

Frequency

Once daily oral (product-dependent)

Half-life

Oral precursor PK (not a peptide t½)

Common vials

N/A (oral)

CAS

1094-61-7

Molecular weight

~334.2 g/mol

Use-case scores

0–10 against the evidence we have, not a gym ranking. Hidden domains do not apply here.

Longevity / aging4/10
Human PK and metabolic studies exist. Not a lifespan NDA. Not interchangeable with IV NAD+. Score 4.

Compound card

Sequence: Nicotinamide mononucleotide (β-NMN; not a peptide)
Class: Oral NAD+ precursor (supplement / research ingredient)
Formula: C11H15N2O8P
Status: Not FDA-approved · research use

How it works

NMN (nicotinamide mononucleotide) is an oral NAD+ salvage-pathway precursor. Cells convert it toward NAD+. It is not injectable NAD+ clinic folklore, not NR on this leaf, and not a peptide reconstitution job.

The NAD+ leaf covers the coenzyme identity. This leaf exists because people search NMN as its own SKU.

Source: NMN human pharmacokinetic and metabolic literature; FDA/DSHEA status has shifted by jurisdiction and year — this leaf is identity, not purchase advice

Research Use Cases

✓NAD+ precursor literacy: Moderate
✓Peptide reconstitution: Low

Dosing

Phase	Dose	Frequency	Notes
Oral products	Per product label / studied oral bands	Once daily oral	Typically hundreds of mg in human studies. Follow the product. Not a vial.

Administration

Route / form

Oral

Timing

Daily per product

Empty stomach?

No - Food timing is not critical.

Timeline

Days to weeks

NAD+-related biomarker changes in studies — not a peptide recovery curve.

Who it is for

NAD+ precursor literacy

Moderate

Common search next to NAD+. Keep routes straight.

Peptide reconstitution

Low

Wrong category.

Safety & Considerations

Oral ingredient. Flushing and GI effects can occur. Not a substitute for clinic NAD+ protocols or diagnosed mitochondrial disease care.

Regulatory & Legal Status

FDA Status (US)

Research Only

WADA Status (2026)

Not Listed

Not currently on the WADA 2026 Prohibited List. Policies may change - verify before competition.

Classification

Research Chemical

US Compounding: Not eligible / not available

⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.

Limits of current evidence

Not a peptide. No BAC-water chart.
Not the same exposure as IV/SubQ NAD+.
Not automatically identical to NR.
Regulatory status for NMN as a supplement has shifted by jurisdiction and year — this leaf is identity, not purchase advice.
This site will not treat aging from an NMN page.

Verdict

NMN is an oral NAD+ precursor, not a peptide and not IV NAD+. Use the NAD+ leaf for the coenzyme. Do not put NMN in the reconstitution calculator.

Interactions & Contraindications

Oral ingredient. Flushing and GI effects can occur. Not a substitute for clinic NAD+ protocols or diagnosed mitochondrial disease care.

Appears in goal guides

Goal guides are maps, not clinic protocols. A mention here is not a treatment plan.

Anti-Aging & Cellular Longevity

Educational map of GH secretagogues, pineal cytogens, and dermal peptides used in longevity folklore. Telomerase and “youthful gene expression” are not a US anti-aging indication.

View Protocol →